Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use ONZETRA Xsail safely and effectively. See full prescribing information for ONZETRA Xsail. ONZETRA® Xsail® (sumatriptan nasal powder) Initial U.S. Approval: 1992
Medication labelWhy this: Advisory · dailymed-prescription
ONZETRA® Xsail® is indicated for the acute treatment of migraine with or without aura in adults. Limitations of Use Use only if a clear diagnosis of migraine has been established. If a patient has no response to the first migraine attack treated with ONZETRA Xsail, reconsider the diagnosis of migraine before treatment of subsequent attacks with ONZETRA Xsail. ONZETRA Xsail is not indicated for the prevention of migraine attacks. Safety and effectiveness of ONZETRA Xsail have not been established for the treatment of cluster headache.
- generic_name
- sumatriptan succinate
- product_names
- sumatriptan succinate
- ndc
- 42847-311, 42847-311-08
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en